The present invention is directed to sustained-release pharmaceutical
formulations of therapeutic proteins containing carboxymethyl ether
cellulose polymer and methods of manufacture and use thereof.
A invenção atual é dirigida sustent-libera formulations pharmaceutical das proteínas therapeutic que contêm o polímero carboxymethyl da celulose do ether e os métodos da manufatura e usa-se disso.
